FDA hears transparency boost ideas

Share this article:
At its first public hearing in June, the FDA's new Transparency Task Force heard diverse ideas ranging from greater news media access to FDA staff to separate consumer and professional web portals to writing legal documents in consumer-friendly language.

One of the most forceful presentations came from freelance healthcare journalist Kathryn Foxhall, who protested restrictions on reporters' access to FDA staff that she said significantly hinders the ability of the news media to do its job. This has been the subject of complaints from the Society of Professional Journalists and the Association of Healthcare Journalists. Restrictions in place represent “severe censorship,” she declared.

In the past, she said, reporters were able to work agency beats by walking the halls, stopping to talk with and develop relations with staff at all levels, identifying over time those sources who were able to provide the kinds of education and information that they needed to write stories of use to their audiences. But through changes made in the last two presidential administrations, she said, it can now take days to get permission to talk with someone and increasingly permission is never granted.

Anyone calling an FDA staffer should get the same level of help and service, she said, whether from an industry, the news media, a consumer group or a congressional committee.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?